ArticleApplied biochemistry and biotechnology2026
Protopine-Enriched Dactylicapnos Scandens Root Fraction Improves Glucose Homeostasis in Cell and Mouse Models Via AMPK/PEPCK/G6Pase Modulation.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Dactylicapnos scandens (D. Don) Hutch is popular among traditional healthcare providers in Nagaland, North-East India and Bai communities in China. Current investigation analyses traditional claims of Dactylicapnos scandens root tuber extract to control diabetes through down-regulation of hepatic gluconeogenesis and oxidative stress in diabetes mellitus (Type 2) in both in vitro (cell culture) and in vivo (animal model) systems. Potential of Dactylicapnos scandens against diabetes was demonstrated in free fatty acid (FFA)-induced CC1 liver cells and streptozotocin-induced diabetic male Swiss albino mice. Enriched bioactive fraction was prepared through activity guided fractionation and major component was identified to be protopine. Enriched fraction of Dactylicapnos scandens root tuber and its isolated compound, protopine increased glucose uptake by the liver cells in FFA-induced condition. Further, the enriched fraction down regulated gluconeogenesis enzymes (Glucose-6-phosphatase and phosphoenolpyruvate kinase) through AMP-activated protein kinase (AMPK) modulation in both CC1 liver cells and liver tissues of diabetic mice. Moreover, in vivo experiment with enriched fraction containing protopine enhanced the tolerance of glucose as well as insulin level in plasma. Antidiabetic activity of enriched fraction containing protopine as a major component was also supported by histopathological analysis. Overall, protopine containing root tuber enriched fraction of Dactylicapnos scandens regulates antihyperglycemic efficacy in CC1 liver cells and in Swiss albino mice induced with diabetes via ameliorating AMPK/PEPCK/G6Pase signalling pathway.
Indexed as
Identifiers
41485169What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.